FROST PHILLIP MD ET AL purchased 3.8% of their position (65K shares) of COCRYSTAL PHARMA, INC. on the open market
Open‑market purchase worth $63.2K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 12/29/2025ACC: 0001493152-25-029257
Director10% Owner
Since Feb 2026
+65K
Net shares
Net buyer
$63.2K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
65K acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+25K
Price / share
$0.97
Trade value
$24.26K
% of position
1.5%
12/24/2025
1.70M→1.73M
Common Stock
Indirect
Shares
+40K
Price / share
$0.97
Trade value
$38.94K
% of position
2.3%
12/26/2025
1.73M→1.77M
Total
Net shares
+65K
Net value
$63.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 12/24/2025 | P · Purchase | +25K | $0.97 | $24.26K | 1.5% | 1.70M | 1.73M |
| Common Stock Indirect | 12/26/2025 | P · Purchase | +40K | $0.97 | $38.94K | 2.3% | 1.73M | 1.77M |
| Total | +65K | $63.20K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned27.10K
Total
27.10K direct27.10K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 27.10K | Direct |
| Total | 27.10K | 27.10K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported